This Cancer Research Catalyst blog reports on the release of the sixth annual AACR Cancer Progress Report, which highlights how federally funded research powers progress against cancer.
Combining Cytokine-based Immunotherapy AM0010 with Pembrolizumab Yielded Durable Responses in Patients with Advanced Solid Tumors
Ratio of Certain Immune Cells to Tumor Burden Correlated With Outcome For Pembrolizumab-treated Patients With Melanoma
AACR, Founding Organizer and Lead Sponsor of the Fourth Annual Rally for Medical Research Hill Day, to Advocate for Continued Growth in Federal Funding for the NIH
American Association for Cancer Research Releases 2016 Cancer Progress Report: Research is Saving Lives
Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, Sept. 25-28, 2016
AACR Conference on The Science of Cancer Health Disparities, Sept. 25-28, 2016
San Antonio Breast Cancer Symposium, Dec. 6-10, 2016
AACR Annual Meeting 2017, April 1-5, 2017
This Cancer Research Catalyst blog post discusses new research published in the AACR journal Cancer Research.
Philly.com reported on the release of this year’s AACR Cancer Progress Report.